Skip to main content
. 2011 Nov 1;73(5):706–716. doi: 10.1111/j.1365-2125.2011.04137.x

Figure 6.

Figure 6

The relationship between PF-04457845 plasma concentrations and FAAH1 inhibition at doses up to 10 mg PF-04457845 (SRD study), 0.1 mg (●), 0.3 mg (○), 1 mg (▴), 3 mg (▵), 10 mg (Inline graphic). (Higher doses are entirely compatible with the emergent pattern but are not included as the amount of data at high concentrations obscures the relationship.)

HHS Vulnerability Disclosure